Your right after the R/S you will have less shares, and you know as well as i that the MM's will push and short this back down to penny's. i've seen it happen time after time. R/S is most always seen as a sign of desperation and mismanagement.. Investors will not want to touch this stock after R/S.. The BoD and CEO will in my opinion issue themselves shares as bonuses and dilution will start all over again. Genta is a good example of want happens after a R/S..There stock after split was worth around .50 now it sub penny again...
After the R/S proposal vote and if it is approved I will be looking for an exit point to minumise my loses....
I Will Vote No on This R/S Proposal ....and I Hope Other Investors Do The same...
I don't think its the split that bothers some of us so much as its the MASS DILUTION that is promised to follow which in turn as we all know will be the actual cause of the PPS to take a nosedive! THIS in turn gives the shareholder LESS shares and a reward of LESS PPS as well....as one on this board described it..a stab in the back with a twist!
For me...a smaller split would be acceptable to accomplish what goals the CEO has in his plan to allow CBAI to go forward...maybe not as fast as he would like to see but forward none the less...SHOW SOME REVS!
TO go along with the smaller split...A LIMIT on dilution (if any at all) and a specific PLAN for the dilution NOT TO INCLUDE executive bonuses...(just another golden parachute IMO) or employee stock options. Theres plenty of time for those options AFTER shareholders are rewarded...when there's enough to go around. REWARD the SHAREHOLDERS FIRST...we took the risk in order to get this company to where it is now...NOT the potential investors on the sidelines.
If anyones answer to this is Matt's plan needs more money to continue and the only way to get there is to screw us...then he's not they type CEO we were led to believe he was and his plan sucked.
I'd rather the company go into bankruptcy and have big pharma buy it out than continue with purchases that show no revs...a declining PPS...and a continuence of a plan that constantly runs out of money and needs to dilute in order to stay afloat.
I'll take my chances with a big pharma buyout that has a CEO with a better plan.
Time will tell, but WHAT IF the pps continues to decline prior to the RS because good ol' Matt continues to keep us in the dark... If we hit .002 at split time we will barely make $1 post split and the pps will no doubt decline from there. Uplist... Yeah Right... I'll believe it when it HAPPENS (personally I'm not buying it)
As has been pointed out many times already, a whole new round of dilution is about to begin!
Wouldn't surprise me to be down at 50 cents or less within a year.
The only thing that is CERTAIN is that Matt just screwed us all.